{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:16:48Z","timestamp":1790745408977,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"19","license":[{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo (ANID) de Chile: Fondecyt Regular","award":["1190775"],"award-info":[{"award-number":["1190775"]}]},{"name":"ANID-Basal funding for Scientific and Technological Center of Excellence, IMPACT","award":["FB210024"],"award-info":[{"award-number":["FB210024"]}]},{"name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo (ANID) de Chile: Fondecyt de Iniciaci\u00f3n","award":["11180531"],"award-info":[{"award-number":["11180531"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00432-023-05443-1","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T04:01:51Z","timestamp":1697169711000},"page":"17335-17346","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["CCR5\/CCL5 axis is linked to a poor outcome, and inhibition reduces metastasis in oral squamous cell carcinoma"],"prefix":"10.1007","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0563-4948","authenticated-orcid":false,"given":"Wilfredo Alejandro","family":"Gonz\u00e1lez-Arriagada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo D.","family":"Coletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Lozano-Burgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Maripill\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Alcayaga-Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basti\u00e1n","family":"God\u00ednez-Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebasti\u00e1n","family":"Oyarce-Pezoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Mart\u00ednez-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac E.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,13]]},"reference":[{"issue":"3","key":"5443_CR1","doi-asserted-by":"publisher","first-page":"20180272","DOI":"10.1259\/dmfr.20180272","volume":"48","author":"A Baba","year":"2019","unstructured":"Baba A, Okuyama Y, Ikeda K, Kozakai A, Suzuki T, Saito H, Ogane S, Yamazoe S, Yamauchi H, Ogino N, Seto Y, Kobashi Y, Mogami T, Ojiri H (2019) Undetectability of oral tongue cancer on magnetic resonance imaging; clinical significance as a predictor to avoid unnecessary elective neck dissection in node negative patients. Dentomaxillofac Radiol 48(3):20180272. https:\/\/doi.org\/10.1259\/dmfr.20180272","journal-title":"Dentomaxillofac Radiol"},{"issue":"18","key":"5443_CR2","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.7150\/ijms.51126","volume":"17","author":"S Bai","year":"2020","unstructured":"Bai S, Wu Y, Yan Y, Kang H, Zhang J, Ma W, Gao Y, Hui B, Zhang X, Ren J (2020) The effect of CCL5 on the immune cells infiltration and the prognosis of patients with kidney renal clear cell carcinoma. Int J Med Sci 17(18):2917\u20132925. https:\/\/doi.org\/10.7150\/ijms.51126","journal-title":"Int J Med Sci"},{"issue":"12","key":"5443_CR3","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1002\/ptr.6780","volume":"34","author":"GA Borges","year":"2020","unstructured":"Borges GA, Elias ST, Amorim B, de Lima CL, Coletta RD, Castilho RM, Squarize CH, Silva EN (2020) Curcumin downregulates the PI3K-AKT-mTOR pathway and inhibits growth and progression in head and neck cancer cells. Phytother Res 34(12):3311\u20133324. https:\/\/doi.org\/10.1002\/ptr.6780","journal-title":"Phytother Res"},{"issue":"3","key":"5443_CR4","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s11596-011-0378-3","volume":"31","author":"Z Cao","year":"2011","unstructured":"Cao Z, Xu X, Luo X, Li L, Huang B, Li X, Tao D, Hu J, Gong J (2011) Role of RANTES and its receptor in gastric cancer metastasis. J Huazhong Univ Sci Technolog Med Sci 31(3):342\u2013347. https:\/\/doi.org\/10.1007\/s11596-011-0378-3","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"issue":"12","key":"5443_CR5","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.ijom.2020.03.009","volume":"49","author":"A Capote-Moreno","year":"2020","unstructured":"Capote-Moreno A, Brabyn P, Mu\u00f1oz-Guerra MF, Sastre-Perez J, Escorial-Hernandez V, Rodr\u00edguez-Campo FJ, Garc\u00eda T, Naval-G\u00edas L (2020) Oral squamous cell carcinoma: epidemiological study and risk factor assessment based on a 39-year series. Int J Oral Maxillofac Surg 49(12):1525\u20131534. https:\/\/doi.org\/10.1016\/j.ijom.2020.03.009","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"5","key":"5443_CR6","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.prp.2019.02.011","volume":"215","author":"M Chen","year":"2019","unstructured":"Chen M, Yang X, Yang M, Zhang W, Li L, Sun Q (2019) Identification of a novel biomarker-CCL5 using antibody microarray for colorectal cancer. Pathol Res Pract 215(5):1033\u20131037. https:\/\/doi.org\/10.1016\/j.prp.2019.02.011","journal-title":"Pathol Res Pract"},{"issue":"2","key":"5443_CR7","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/jcp.21783","volume":"220","author":"JY Chuang","year":"2009","unstructured":"Chuang JY, Yang WH, Chen HT, Huang CY, Tan TW, Lin YT, Hsu CJ, Fong YC, Tang CH (2009) CCL5\/CCR5 axis promotes the motility of human oral cancer cells. J Cell Physiol 220(2):418\u2013426. https:\/\/doi.org\/10.1002\/jcp.21783","journal-title":"J Cell Physiol"},{"key":"5443_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.oraloncology.2016.02.016","volume":"56","author":"JM da Silva","year":"2016","unstructured":"da Silva JM, Soave DF, Moreira TP, Batista AC, Russo RC, Teixeira MM, da Silva TA (2016) Significance of chemokine and chemokine receptors in head and neck squamous cell carcinoma: a critical review. Oral Oncol 56:8\u201316. https:\/\/doi.org\/10.1016\/j.oraloncology.2016.02.016","journal-title":"Oral Oncol"},{"issue":"3","key":"5443_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002314","volume":"95","author":"TS Dantas","year":"2016","unstructured":"Dantas TS, de Barros PG, Sousa EF, da Cunha MDP, de Aguiar ASW, Costa FWG, Mota MRL, Alves AP, Sousa FB (2016) Influence of educational level, stage, and histological type on survival of oral cancer in a Brazilian population: a retrospective study of 10 years observation. Med 95(3):e2314. https:\/\/doi.org\/10.1097\/MD.0000000000002314","journal-title":"Med"},{"issue":"4","key":"5443_CR10","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s13193-012-0173-z","volume":"3","author":"SV Deo","year":"2012","unstructured":"Deo SV, Shukla NK, Jha D, Khanna P, Pandit A, Thulkar S (2012) Are We over-treating neck in buccal & alveolo-buccal cancers: experience from a tertiary cancer care center. Indian J Surg Oncol 3(4):272\u2013275. https:\/\/doi.org\/10.1007\/s13193-012-0173-z","journal-title":"Indian J Surg Oncol"},{"issue":"3","key":"5443_CR11","doi-asserted-by":"publisher","first-page":"e354","DOI":"10.4317\/medoral.22904","volume":"24","author":"CB Domingueti","year":"2019","unstructured":"Domingueti CB, Janini JBM, Parana\u00edba RLM, Lozano-Burgos C, Olivero P, Gonz\u00e1lez-Arriagada WA (2019) Prognostic value of immunoexpression of CCR4, CCR5, CCR7 and CXCR4 in squamous cell carcinoma of tongue and floor of the mouth. Med Oral Patol Oral Cir Bucal 24(3):e354\u2013e363. https:\/\/doi.org\/10.4317\/medoral.22904","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"5443_CR12","doi-asserted-by":"publisher","first-page":"1085917","DOI":"10.3389\/fonc.2022.1085917","volume":"12","author":"MR Dourado","year":"2022","unstructured":"Dourado MR, Elseragy A, da Costa BC, T\u00e9o FH, Guimar\u00e3es GN, Machado RA, Risteli M, Wahbi W, Gurgel CA, Ribeiro LM, Gonz\u00e1lez-Arriagada WA, da Silva SD, Carrinho AL, Rocha M, Rossa C, Salo T, Coletta RD (2022) Stress induced phosphoprotein 1 overexpression controls proliferation, migration and invasion and is associated with poor survival in oral squamous cell carcinoma. Front Oncol 12:1085917. https:\/\/doi.org\/10.3389\/fonc.2022.1085917","journal-title":"Front Oncol"},{"issue":"8","key":"5443_CR13","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.joms.2018.02.009","volume":"76","author":"T Gao","year":"2018","unstructured":"Gao T, Shen Z, Ma C, Li Y, Kang X, Sun M (2018) The CCL5\/CCR5 chemotactic pathway promotes perineural invasion in salivary adenoid cystic carcinoma. J Oral Maxillofac Surg 76(8):1708\u20131718. https:\/\/doi.org\/10.1016\/j.joms.2018.02.009","journal-title":"J Oral Maxillofac Surg"},{"key":"5443_CR14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41392-020-00267-8","volume":"5","author":"R Gong","year":"2020","unstructured":"Gong R, Ren H (2020) Targeting chemokines\/chemokine receptors: a promising strategy for enhancing the immunotherapy of pancreatic ductal adenocarcinoma. Signal Transduct Target Ther 5:149. https:\/\/doi.org\/10.1038\/s41392-020-00267-8","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"5443_CR15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/jop.12736","volume":"47","author":"WA Gonzalez-Arriagada","year":"2018","unstructured":"Gonzalez-Arriagada WA, Lozano-Burgos C, Zuniga-Moreta R, Gonzalez-Diaz P, Coletta RD (2018) Clinicopathological significance of chemokine receptor (CCR1, CCR3, CCR4, CCR5, CCR7 and CXCR4) expression in head and neck squamous cell carcinomas. J Oral Pathol Med 47(8):755\u2013763. https:\/\/doi.org\/10.1111\/jop.12736","journal-title":"J Oral Pathol Med"},{"issue":"1","key":"5443_CR16","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3390\/ijms24010478","volume":"24","author":"WA Gonzalez-Arriagada","year":"2022","unstructured":"Gonzalez-Arriagada WA, Garcia IE, Martinez-Flores R, Morales-Pison S, Coletta RD (2022) Therapeutic perspectives of HIV-associated chemokine receptor (CCR5 and CXCR4) antagonists in carcinomas. Int J Mol Sci 24(1):478. https:\/\/doi.org\/10.3390\/ijms24010478","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5443_CR17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/tox.23675","volume":"38","author":"B Guan","year":"2023","unstructured":"Guan B, Li H, Yao J, Guo J, Yu F, Li G, Wan B, Ma J, Huang D, Sun L, Chen Y (2023) CCL3-CCR5 axis promotes cell migration and invasion of colon adenocarcinoma via Akt signaling pathway. Environ Toxicol 38(1):172\u2013184. https:\/\/doi.org\/10.1002\/tox.23675","journal-title":"Environ Toxicol"},{"issue":"1","key":"5443_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/QAI.0b013e3182a7a97a","volume":"65","author":"RM Gulick","year":"2014","unstructured":"Gulick RM, Fatkenheuer G, Burnside R, Hardy WD, Nelson MR, Goodrich J, Mukwaya G, Portsmouth S, Heera JR (2014) Five-year safety evaluation of maraviroc in HIV-1-infected treatment-experienced patients. J Acquir Immune Defic Syndr 65(1):78\u201381. https:\/\/doi.org\/10.1097\/QAI.0b013e3182a7a97a","journal-title":"J Acquir Immune Defic Syndr"},{"key":"5443_CR19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ejca.2022.03.017","volume":"167","author":"GM Haag","year":"2022","unstructured":"Haag GM, Springfeld C, Gr\u00fcn B, Apostolidis L, Zsch\u00e4bitz S, Dietrich M, Berger AK, Weber TF, Zoernig I, Schaaf M, Waberer L, M\u00fcller DW, Al-Batran SE, Niels H, Jaeger D (2022) Pembrolizumab and maraviroc in refractory mismatch repair proficient\/microsatellite-stable metastatic colorectal cancer\u2014the PICCASSO phase I trial. Eur J Cancer 167:112\u2013122. https:\/\/doi.org\/10.1016\/j.ejca.2022.03.017","journal-title":"Eur J Cancer"},{"issue":"6","key":"5443_CR20","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1150398","volume":"5","author":"EC Halvorsen","year":"2016","unstructured":"Halvorsen EC, Hamilton MJ, Young A, Wadsworth BJ, LePard NE, Lee HN, Firmino N, Collier JL, Bennewith KL (2016) Maraviroc decreases CCL8-mediated migration of CCR5(+) regulatory T cells and reduces metastatic tumor growth in the lungs. Oncoimmunology 5(6):e1150398. https:\/\/doi.org\/10.1080\/2162402X.2016.1150398","journal-title":"Oncoimmunology"},{"issue":"4","key":"5443_CR21","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1080\/14728222.2021.1902505","volume":"25","author":"H Hemmatazad","year":"2021","unstructured":"Hemmatazad H, Berger MD (2021) CCR5 is a potential therapeutic target for cancer. Expert Opin Ther Targets 25(4):311\u2013327. https:\/\/doi.org\/10.1080\/14728222.2021.1902505","journal-title":"Expert Opin Ther Targets"},{"key":"5443_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.canlet.2020.01.009","volume":"474","author":"H Huang","year":"2020","unstructured":"Huang H, Zepp M, Georges RB, Jarahian M, Kazemi M, Eyol E, Berger MR (2020) The CCR5 antagonist maraviroc causes remission of pancreatic cancer liver metastasis in nude rats based on cell cycle inhibition and apoptosis induction. Cancer Lett 474:82\u201393. https:\/\/doi.org\/10.1016\/j.canlet.2020.01.009","journal-title":"Cancer Lett"},{"key":"5443_CR23","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.2147\/OTT.S279189","volume":"14","author":"R Huang","year":"2021","unstructured":"Huang R, Guo L, Gao M, Li J, Xiang S (2021) Research trends and regulation of CCL5 in prostate cancer. Onco Targets Ther 14:1417\u20131427. https:\/\/doi.org\/10.2147\/OTT.S279189","journal-title":"Onco Targets Ther"},{"issue":"23","key":"5443_CR24","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1182\/blood-2012-06-436345","volume":"121","author":"PW Hunt","year":"2013","unstructured":"Hunt PW, Shulman NS, Hayes TL, Dahl V, Somsouk M, Funderburg NT, McLaughlin B, Landay AL, Adeyemi O, Gilman LE, Clagett B, Rodriguez B, Martin JN, Schacker TW, Shacklett BL, Palmer S, Lederman MM, Deeks SG (2013) The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial. Blood 121(23):4635\u20134646. https:\/\/doi.org\/10.1182\/blood-2012-06-436345","journal-title":"Blood"},{"key":"5443_CR25","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13058-018-0981-3","volume":"20","author":"K Jin","year":"2018","unstructured":"Jin K, Pandey NB, Popel AS (2018) Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis. Breast Cancer Res 20:54. https:\/\/doi.org\/10.1186\/s13058-018-0981-3","journal-title":"Breast Cancer Res"},{"key":"5443_CR26","doi-asserted-by":"publisher","first-page":"16351","DOI":"10.1038\/s41598-019-52746-w","volume":"9","author":"G Kalpana","year":"2019","unstructured":"Kalpana G, Figy C, Yeung M, Yeung KC (2019) Reduced RhoA expression enhances breast cancer metastasis with a concomitant increase in CCR5 and CXCR4 chemokines signaling. Sci Rep 9:16351. https:\/\/doi.org\/10.1038\/s41598-019-52746-w","journal-title":"Sci Rep"},{"key":"5443_CR27","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/s41374-020-0441-4","volume":"100","author":"T Kodama","year":"2020","unstructured":"Kodama T, Koma YI, Arai N, Kido A, Urakawa N, Nishio M, Shigeoka M, Yokozaki H (2020) CCL3-CCR5 axis contributes to progression of esophageal squamous cell carcinoma by promoting cell migration and invasion via Akt and ERK pathways. Lab Invest 100:1140\u20131157. https:\/\/doi.org\/10.1038\/s41374-020-0441-4","journal-title":"Lab Invest"},{"issue":"12","key":"5443_CR28","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.ijom.2022.04.005","volume":"51","author":"ES Kolegova","year":"2022","unstructured":"Kolegova ES, Patysheva MR, Larionova IV, Fedorova IK, Kulbakin DE, Choinzonov EL, Denisov EV (2022) Early-onset oral cancer as a clinical entity: aetiology and pathogenesis. Int J Oral Maxillofac Surg 51(12):1497\u20131509. https:\/\/doi.org\/10.1016\/j.ijom.2022.04.005","journal-title":"Int J Oral Maxillofac Surg"},{"key":"5443_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s41065-022-00251-y","volume":"159","author":"C Li","year":"2022","unstructured":"Li C, Chen S, Liu C, Mo C, Gong W, Hu J, He M, Xie L, Hou X, Tang J, Ou M (2022a) CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic study. Hereditas 159:37. https:\/\/doi.org\/10.1186\/s41065-022-00251-y","journal-title":"Hereditas"},{"issue":"2","key":"5443_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.147","volume":"3","author":"H Li","year":"2022","unstructured":"Li H, Wu M, Zhao X (2022b) Role of chemokine systems in cancer and inflammatory diseases. MedComm 3(2):e147. https:\/\/doi.org\/10.1002\/mco2.147","journal-title":"MedComm"},{"key":"5443_CR31","doi-asserted-by":"publisher","first-page":"15446","DOI":"10.1038\/s41598-021-95007-5","volume":"11","author":"NC Lin","year":"2020","unstructured":"Lin NC, Hsien SI, Hsu JT, Chen MYC (2020) Impact on patients with oral squamous cell carcinoma in different anatomical subsites: a single-center study in Taiwan. Sci Rep 11:15446. https:\/\/doi.org\/10.1038\/s41598-021-95007-5","journal-title":"Sci Rep"},{"issue":"7","key":"5443_CR32","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1002\/ijc.33352","volume":"148","author":"Z Ling","year":"2021","unstructured":"Ling Z, Cheng B, Tao X (2021) Epithelial-to-mesenchymal transition in oral squamous cell carcinoma: challenges and opportunities. Int J Cancer 148(7):1548\u20131561. https:\/\/doi.org\/10.1002\/ijc.33352","journal-title":"Int J Cancer"},{"key":"5443_CR33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ctrv.2018.03.001","volume":"65","author":"MV Madera","year":"2018","unstructured":"Madera MV, Franco JV, Merchan-Galvis AM, Gallardo CR, Bonfill X (2018) Quality assessment of clinical practice guidelines on treatments for oral cancer. Cancer Treat Rev 65:47\u201353. https:\/\/doi.org\/10.1016\/j.ctrv.2018.03.001","journal-title":"Cancer Treat Rev"},{"issue":"21","key":"5443_CR34","doi-asserted-by":"publisher","first-page":"4338","DOI":"10.1182\/bloodadvances.2021004203","volume":"5","author":"B Manfroi","year":"2021","unstructured":"Manfroi B, De Grandis M, Moreaux J, Tabruyn S, Mayol JF, Quintero M, Righini C, Sturm N, Aurrand-Lions M, Huard B (2021) The microenvironment of DLBCL is characterized by noncanonical macrophages recruited by tumor-derived CCL5. Blood Adv 5(21):4338\u20134351. https:\/\/doi.org\/10.1182\/bloodadvances.2021004203","journal-title":"Blood Adv"},{"issue":"6","key":"5443_CR35","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1593\/tlo.13499","volume":"6","author":"A Mencarelli","year":"2013","unstructured":"Mencarelli A, Graziosi L, Renga B, Cipriani S, D\u2019Amore C, Francisci D, Bruno A, Baldelli F, Donini A, Fiorucci S (2013) CCR5 antagonism by maraviroc reduces the potential for gastric cancer cell dissemination. Transl Oncol 6(6):784\u2013793. https:\/\/doi.org\/10.1593\/tlo.13499","journal-title":"Transl Oncol"},{"issue":"12","key":"5443_CR36","doi-asserted-by":"publisher","first-page":"6987","DOI":"10.21873\/anticanres.14723","volume":"40","author":"N Neckel","year":"2020","unstructured":"Neckel N, Michael M, Troeltzsch D, W\u00fcster J, Koerdt S, Doll C, J\u00f6hrens K, Neumann K, Heiland M, Raguse JD (2020) Rediscussing the role of traditional risk factors in young adults with oral squamous cell carcinoma. Anticancer Res 40(12):6987\u20136995. https:\/\/doi.org\/10.21873\/anticanres.14723","journal-title":"Anticancer Res"},{"key":"5443_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2020.105848","volume":"128","author":"JOS Onyeisi","year":"2020","unstructured":"Onyeisi JOS, Pernambuco PCA, Mesquita APS, Azevedo LC, Nader HB, Lopes CC (2020) Effects of syndecan-4 gene silencing by micro RNA interference in anoikis resistant endothelial cells: Syndecan-4 silencing and anoikis resistance. Int J Biochem Cell Biol 128:105848. https:\/\/doi.org\/10.1016\/j.biocel.2020.105848","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"5443_CR38","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s12032-015-0607-x","volume":"32","author":"A Pervaiz","year":"2015","unstructured":"Pervaiz A, Ansari S, Berger MR, Adwan H (2015) CCR5 blockage by maraviroc induces cytotoxic and apoptotic effects in colorectal cancer cells. Med Oncol 32(5):158. https:\/\/doi.org\/10.1007\/s12032-015-0607-x","journal-title":"Med Oncol"},{"issue":"1","key":"5443_CR39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s13402-018-0415-3","volume":"42","author":"A Pervaiz","year":"2019","unstructured":"Pervaiz A, Zepp M, Mahmood S, Ali DM, Berger MR, Adwan H (2019) CCR5 blockage by maraviroc: a potential therapeutic option for metastatic breast cancer. Cell Oncol (dordr) 42(1):93\u2013106. https:\/\/doi.org\/10.1007\/s13402-018-0415-3","journal-title":"Cell Oncol (dordr)"},{"issue":"9","key":"5443_CR40","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1093\/jac\/dkz227","volume":"74","author":"S Piconi","year":"2019","unstructured":"Piconi S, Foschi A, Malagoli A, Carli F, Zona S, Milic J, Ricci ED, Rizzardini G, Guaraldi G (2019) Impact of prolonged maraviroc treatment on non-AIDS-related comorbidities in HIV-positive patients: a retrospective cohort study. J Antimicrob Chemother 74(9):2723\u20132731. https:\/\/doi.org\/10.1093\/jac\/dkz227","journal-title":"J Antimicrob Chemother"},{"key":"5443_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.972383","volume":"12","author":"J Qiu","year":"2022","unstructured":"Qiu J, Xu L, Zeng X, Wu H, Liang F, Lv Q, Du Z (2022) CCL5 mediates breast cancer metastasis and prognosis through CCR5\/Treg cells. Front Oncol 12:972383. https:\/\/doi.org\/10.3389\/fonc.2022.972383","journal-title":"Front Oncol"},{"key":"5443_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2020.104875","volume":"110","author":"L Satgunaseelan","year":"2020","unstructured":"Satgunaseelan L, Allanson BM, Asher R, Reddy R, Low HTH, Veness M, Iyer NG, Smee RI, Palme CE, Gupta R, Clark JR (2020) The incidence of squamous cell carcinoma of the oral tongue is rising in young non-smoking women: an international multi-institutional analysis. Oral Oncol 110:104875. https:\/\/doi.org\/10.1016\/j.oraloncology.2020.104875","journal-title":"Oral Oncol"},{"issue":"1","key":"5443_CR43","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/s41598-018-19643-0","volume":"8","author":"SK Singh","year":"2018","unstructured":"Singh SK, Mishra MK, Eltoum IA, Bae S, Lillard JW Jr, Singh R (2018) CCR5\/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells. Sci Rep 8(1):1323. https:\/\/doi.org\/10.1038\/s41598-018-19643-0","journal-title":"Sci Rep"},{"issue":"4","key":"5443_CR44","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3390\/cancers12040883","volume":"12","author":"SK Singh","year":"2020","unstructured":"Singh SK, Mishra MK, Rivers BM, Gordetsky JB, Bae S, Singh R (2020) Biological and clinical significance of the CCR5\/CCL5 axis in hepatocellular carcinoma. Cancers (basel) 12(4):883. https:\/\/doi.org\/10.3390\/cancers12040883","journal-title":"Cancers (basel)"},{"issue":"9","key":"5443_CR45","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.oraloncology.2011.06.011","volume":"47","author":"LM Sobral","year":"2011","unstructured":"Sobral LM, Bufalino A, Lopes MA, Graner E, Salo T, Coletta RD (2011) Myofibroblasts in the stroma of oral cancer promote tumorigenesis via secretion of activin A. Oral Oncol 47(9):840\u2013846. https:\/\/doi.org\/10.1016\/j.oraloncology.2011.06.011","journal-title":"Oral Oncol"},{"issue":"11","key":"5443_CR46","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3390\/ph13110357","volume":"13","author":"A Somaida","year":"2020","unstructured":"Somaida A, Tariq I, Ambreen G, Abdelsalam AM, Ayoub AM, Wojcik M, Dzoyem JP, Bakowsky U (2020) Potent cytotoxicity of four cameroonian plant extracts on different cancer cell lines. Pharm 13(11):357. https:\/\/doi.org\/10.3390\/ph13110357","journal-title":"Pharm"},{"issue":"4","key":"5443_CR47","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1177\/01945998221098011","volume":"168","author":"KO Stepan","year":"2023","unstructured":"Stepan KO, Mazul AL, Larson J, Shah P, Jackson RS, Pipkorn P, Kang SY, Puram SV (2023) Changing epidemiology of oral cavity cancer in the United States. Otolaryngol Head Neck Surg 168(4):761\u2013768. https:\/\/doi.org\/10.1177\/01945998221098011","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"5","key":"5443_CR48","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/jso.20984","volume":"97","author":"H Sugasawa","year":"2008","unstructured":"Sugasawa H, Ichikura T, Tsujimoto H, Kinoshita M, Morita D, Ono S, Chochi K, Tsuda H, Seki S, Mochizuki H (2008) Prognostic significance of expression of CCL5\/RANTES receptors in patients with gastric cancer. J Surg Oncol 97(5):445\u2013450. https:\/\/doi.org\/10.1002\/jso.20984","journal-title":"J Surg Oncol"},{"issue":"3","key":"5443_CR49","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"5443_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2019.104492","volume":"101","author":"P Szturz","year":"2020","unstructured":"Szturz P, Vermorken JB (2020) Management of recurrent and metastatic oral cavity cancer: raising the bar a step higher. Oral Oncol 101:104492. https:\/\/doi.org\/10.1016\/j.oraloncology.2019.104492","journal-title":"Oral Oncol"},{"issue":"9","key":"5443_CR51","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3390\/biom9090464","volume":"9","author":"M Ucuncu","year":"2019","unstructured":"Ucuncu M, Serilmez M, Sari M, Bademler S, Karabulut S (2019) The diagnostic significance of PDGF, EphA7, CCR5, and CCL5 levels in colorectal cancer. Biomol 9(9):464. https:\/\/doi.org\/10.3390\/biom9090464","journal-title":"Biomol"},{"issue":"15","key":"5443_CR52","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1158\/0008-5472.CAN-11-3917","volume":"72","author":"M Velasco-Velazquez","year":"2012","unstructured":"Velasco-Velazquez M, Jiao X, De La Fuente M, Pestell TG, Ertel A, Lisanti MP, Pestell RG (2012) CCR5 antagonist blocks metastasis of basal breast cancer cells. Cancer Res 72(15):3839\u20133850. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3917","journal-title":"Cancer Res"},{"key":"5443_CR53","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ijsu.2016.07.008","volume":"32","author":"T Wang","year":"2016","unstructured":"Wang T, Wei Y, Tian L, Song H, Ma Y, Yao Q, Feng M, Wang Y, Gao M, Xue Y (2016) C-C motif chemokine ligand 5 (CCL5) levels in gastric cancer patient sera predict occult peritoneal metastasis and a poorer prognosis. Int J Surg 32:136\u2013142. https:\/\/doi.org\/10.1016\/j.ijsu.2016.07.008","journal-title":"Int J Surg"},{"key":"5443_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.721785","volume":"11","author":"L Wang","year":"2021","unstructured":"Wang L, Li L, Zhu G (2021) Role of extracellular vesicles on cancer lymphangiogenesis and lymph node metastasis. Front Oncol 11:721785. https:\/\/doi.org\/10.3389\/fonc.2021.721785","journal-title":"Front Oncol"},{"key":"5443_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.874896","volume":"13","author":"F Wang","year":"2022","unstructured":"Wang F, Tao Z, Tian Z, Jin J, Dong J, Dai Y, Yu W, Tang B, Hu S (2022) CCR5 as a prognostic factor in lower-grade glioma is involved in the remodeling of the tumor microenvironment. Front Genet 13:874896. https:\/\/doi.org\/10.3389\/fgene.2022.874896","journal-title":"Front Genet"},{"issue":"10","key":"5443_CR56","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.oraloncology.2010.07.011","volume":"46","author":"CJ Weng","year":"2010","unstructured":"Weng CJ, Chien MH, Lin CW, Chung TT, Zavras AI, Tsai CM, Mk C, Yang SF (2010) Effect of CC chemokine ligand 5 and CC chemokine receptor 5 genes polymorphisms on the risk and clinicopathological development of oral cancer. Oral Oncol 46(10):767\u2013772. https:\/\/doi.org\/10.1016\/j.oraloncology.2010.07.011","journal-title":"Oral Oncol"},{"issue":"3","key":"5443_CR57","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41416-020-01120-z","volume":"124","author":"F Willenbrock","year":"2021","unstructured":"Willenbrock F, Cox CM, Parkes EE, Wilhelm-Benartzi CS, Abraham AG, Owens R, Sabbagh A, Jones CM, Hughes DLI, Maughan T, Hurt CN, O\u2019Neill EE, Mukherjee S (2021) Circulating biomarkers and outcomes from a randomised phase 2 trial of gemcitabine versus capecitabine-based chemoradiotherapy for pancreatic cancer. Br J Cancer 124(3):581\u2013586. https:\/\/doi.org\/10.1038\/s41416-020-01120-z","journal-title":"Br J Cancer"},{"issue":"2","key":"5443_CR58","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1177\/1533034616629261","volume":"16","author":"L Xu","year":"2017","unstructured":"Xu L, Wu W, Cheng G, Qian M, Hu K, Yin G, Wang S (2017) Enhancement of proliferation and invasion of gastric cancer cell by KDM5C via decrease in p53 expression. Technol Cancer Res Treat 16(2):141\u2013149. https:\/\/doi.org\/10.1177\/1533034616629261","journal-title":"Technol Cancer Res Treat"},{"issue":"1","key":"5443_CR59","doi-asserted-by":"publisher","first-page":"17562","DOI":"10.1038\/s41598-021-96827-1","volume":"11","author":"H Yang","year":"2021","unstructured":"Yang H, Son NH, Lee SH, Kim D, Kim HJ, Cha IH, Nam W (2021) Predictive modelling of level IIb lymph node metastasis in oral squamous cell carcinoma. Sci Rep 11(1):17562. https:\/\/doi.org\/10.1038\/s41598-021-96827-1","journal-title":"Sci Rep"},{"issue":"1","key":"5443_CR60","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.gendis.2021.08.004","volume":"9","author":"Z Zeng","year":"2022","unstructured":"Zeng Z, Lan T, Wei Y, Wei X (2022) CCL5\/CCR5 axis in human diseases and related treatments. Genes Dis 9(1):12\u201327. https:\/\/doi.org\/10.1016\/j.gendis.2021.08.004","journal-title":"Genes Dis"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-05443-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-023-05443-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-05443-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T13:03:36Z","timestamp":1710421416000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-023-05443-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,13]]},"references-count":60,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["5443"],"URL":"https:\/\/doi.org\/10.1007\/s00432-023-05443-1","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,13]]},"assertion":[{"value":"19 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of the article was revised to correct the error in the article title.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For research using human specimens, the study was approved by Research Ethics Committee of the Universidad de los Andes (CEC2022020) and the Research Ethics Committee of the Universidad de Valpara\u00edso (CEC195-19), following the Helsinki Declaration and its later amendments. Approval for the animal experiments was granted by the Bioethics Committee for Animal Studies of Universidad de Valpara\u00edso (BEA135-19) and Universidad de los Andes (CEC2022020). The study was also approved by the Universidad de Valpara\u00edso Biosecurity Committee (BS0001-19).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}